Use of a medication control officer to reduce bias in a clinical trial: lessons learned from the scleroderma lung study.
Hsu VM, Khanna D, Smith E, Filemon T, Whelton S, Lopata M, Davis JC, Polito A, Heck L, Molitor J, Abeles M, Granda J, Korn J, Clements P; Scleroderma Lung Study Group.
Hsu VM, et al.
Clin Trials. 2010 Feb;7(1):85-9. doi: 10.1177/1740774509355838. Epub 2009 Dec 23.
Clin Trials. 2010.
PMID: 20032002